DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
van Hazel GA, Heinemann V, Sharma NK. et al.
SIRFLOX: randomized phase III trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer.
J Clin Oncol 2016;
34 (15) 1723-1731
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.